How to Use Aloe Vera to Eliminate Pox

ACI expects healthcare antiseptic manufacturers to lose most active ingredients
The US Food and Drug Administration (FDA) will ban some 80% of active ingredients currently allowed for use in healthcare antiseptics, the American Cleaning Institute (ACI) expects.
Plans to require manufacturers to submit data demonstrating the safety and efficacy of their antibacterial ingredients were set out in a 2015 proposed rule - and are expected to become law when the final rule is issued. The FDA will assess data submitted by industry and decide whether to classify actives as "generally recognised as safe and effective" (Gras/Grae), or ban their use in the products.
Triclosana href='https://www.echemi.com/products/pid_Seven3714-triclocarban.html'>Triclocarban.
ACI expects triclosan to face a ban in healthcare products as well, along with more than 20 other ingredients, its associate vice president for environmental safety, Paul DeLeo, told CW+BiocidesHub.
Some substances will be banned due to a lack of support by industry, he said. "Companies know it won't get FDA approval so they are not willing to do the additional testing the agency is requiring."
Others will fail because the data to support them is too challenging to generate. The agency, he says, is asking for "new methods that we are not aware of anyone having successfully completed in this space", but it has been willing to give companies more time.
2026-08-25
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
China’s Acrylic Emulsion Leaders Raise Prices by Up to 15% as Monomer Costs Surge
-
FDA Approves Lantheus’ TAUKLARIFY for Alzheimer’s Tau PET Imaging
-
FDA Grants Accelerated Approval to Bristol Myers Squibb’s ZENBEXUS, Launching First CELMoD Therapy in Multiple Myeloma
-
SIBUR’s Massive Siberian Petrochemical Complex Shuts After Drone Attack, LPG Supply Disrupted
-
Sumitomo Chemical Launches Pilot Plant for Ethanol-to-Propylene Process
-
Libya’s Largest Refinery Faces Full Shutdown After Five Rounds of Airstrikes
-
Kemira to Acquire Water Engineering for USD 150 Million
-
Evonik Releases Financial Results Statement and Expects No Recovery in Global Chemical Market Demand in 2026
-
Mitsui, Idemitsu, and Sumitomo Restructure Polyolefins Business
-
Turkey’s BOTAS Expands LNG Supply Portfolio at Gastech 2025
Recommend Reading
-
NextDecade Approves FID for Fourth LNG Train at Rio Grande Project
-
The Capital Undercurrent in the Desert: China’s Banks, Saudi Gas, and the “Absent” Chinese Funds
-
When Soybeans Lose Weight, Fertilizers Take the Stage: The Industrial Chain Reaction Behind U.S. Farm Subsidies
-
Kemira to Acquire SIDRA Wasserchemie, Expanding European Water Treatment Footprint
-
Laboratoire PYC showcases its collagen-driven nutricosmetic innovations
-
Negotiation Expectations Warming Up Trigger Geopolitical Premium Retreat, Crude Oil Significantly Corrects
-
This week, the market price of epichlorohydrin showed a significant downward trend in China (9.15-9.19)
-
This Week's Activated Carbon Prices Remain Stable (9.15-9.19) in China
-
This week, the Aniline market in China saw a slight increase (9.15-9.19)
-
This Week, the Focus is on Consolidation in China's Titanium Dioxide Market (9.15-9.19)